Zhao Jingsi, Florentin Jonathan, Tai Yi-Yin, Torrino Stéphanie, Ohayon Lee, Brzoska Tomasz, Tang Ying, Yang Jimin, Negi Vinny, Woodcock Chen-Shan Chen, Risbano Michael G, Nouraie Seyed Mehdi, Sundd Prithu, Bertero Thomas, Dutta Partha, Chan Stephen Y
Center for Pulmonary Vascular Biology and Medicine, Pittsburgh Heart, Lung, Blood Vascular Medicine Institute (J.Z., J.F., Y.-Y.T., L.O., T. Brzoska, Y.T., J.Y., V.N., C.-S.C.W., M.G.R., S.M.N., P.S., P.D., S.Y.C.), University of Pittsburgh School of Medicine and UPMC, Pittsburgh, PA.
Université Côte d'Azur, CNRS, IPMC, Valbonne, France (S.T., T. Bertero).
Circ Res. 2020 Aug 14;127(5):677-692. doi: 10.1161/CIRCRESAHA.119.316398. Epub 2020 Jun 4.
Unproven theories abound regarding the long-range uptake and endocrine activity of extracellular blood-borne microRNAs into tissue. In pulmonary hypertension (PH), microRNA-210 (miR-210) in pulmonary endothelial cells promotes disease, but its activity as an extracellular molecule is incompletely defined.
We investigated whether chronic and endogenous endocrine delivery of extracellular miR-210 to pulmonary vascular endothelial cells promotes PH.
Using replete (wild-type [WT]) and knockout mice, we tracked blood-borne miR-210 using bone marrow transplantation and parabiosis (conjoining of circulatory systems). With bone marrow transplantation, circulating miR-210 was derived predominantly from bone marrow. Via parabiosis during chronic hypoxia to induce miR-210 production and PH, miR-210 was undetectable in knockout-knockout mice pairs. However, in plasma and lung endothelium, but not smooth muscle or adventitia, miR-210 was observed in knockout mice of WT-knockout pairs. This was accompanied by downregulation of miR-210 targets ISCU (iron-sulfur assembly proteins)1/2 and COX10 (cytochrome c oxidase assembly protein-10), indicating endothelial import of functional miR-210. Via hemodynamic and histological indices, knockout-knockout pairs were protected from PH, whereas knockout mice in WT-knockout pairs developed PH. In particular, pulmonary vascular engraftment of miR-210-positive interstitial lung macrophages was observed in knockout mice of WT-knockout pairs. To address whether engrafted miR-210-positive myeloid or lymphoid cells contribute to paracrine miR-210 delivery, we studied miR-210 knockout mice parabiosed with miR-210 WT; knockout mice (deficient in myeloid recruitment) or miR-210 WT; knockout mice (deficient in lymphocytes). In both pairs, miR-210 knockout mice still displayed miR-210 delivery and PH, thus demonstrating a pathogenic endocrine delivery of extracellular miR-210.
Endogenous blood-borne transport of miR-210 into pulmonary vascular endothelial cells promotes PH, offering fundamental insight into the systemic physiology of microRNA activity. These results also describe a platform for RNA-mediated crosstalk in PH, providing an impetus for developing blood-based miR-210 technologies for diagnosis and therapy in this disease.
关于细胞外血源性微小RNA在组织中的远距离摄取和内分泌活性,存在大量未经证实的理论。在肺动脉高压(PH)中,肺内皮细胞中的微小RNA-210(miR-210)会促进疾病发展,但其作为细胞外分子的活性尚未完全明确。
我们研究了细胞外miR-210向肺血管内皮细胞的慢性内源性内分泌递送是否会促进肺动脉高压。
我们使用基因完整(野生型[WT])和基因敲除小鼠,通过骨髓移植和联体共生(循环系统连接)追踪血源性miR-210。通过骨髓移植,循环中的miR-210主要来源于骨髓。在慢性低氧诱导miR-210产生和肺动脉高压的过程中,通过联体共生,在基因敲除-基因敲除小鼠对中未检测到miR-210。然而,在野生型-基因敲除小鼠对的基因敲除小鼠的血浆和肺内皮中观察到了miR-210,但在平滑肌或外膜中未观察到。这伴随着miR-210靶标ISCU(铁硫组装蛋白)1/2和COX10(细胞色素c氧化酶组装蛋白-10)的下调,表明功能性miR-210被内皮细胞摄取。通过血流动力学和组织学指标,基因敲除-基因敲除小鼠对可免受肺动脉高压影响,而野生型-基因敲除小鼠对中的基因敲除小鼠则发生了肺动脉高压。特别是,在野生型-基因敲除小鼠对的基因敲除小鼠中观察到miR-210阳性间质肺巨噬细胞在肺血管中植入。为了探究植入的miR-210阳性髓样或淋巴细胞是否有助于旁分泌性miR-210递送,我们研究了与miR-210野生型联体共生的miR-210基因敲除小鼠;基因敲除小鼠(髓样细胞募集缺陷)或miR-210野生型;基因敲除小鼠(淋巴细胞缺陷)。在这两种小鼠对中,miR-210基因敲除小鼠仍表现出miR-210递送和肺动脉高压,从而证明了细胞外miR-210具有致病性内分泌递送作用。
miR-210的内源性血源性运输进入肺血管内皮细胞会促进肺动脉高压,这为深入了解微小RNA活性的全身生理学提供了重要见解。这些结果还描述了肺动脉高压中RNA介导的细胞间通讯平台,为开发基于血液的miR-210技术用于该疾病的诊断和治疗提供了动力。